Diadema Partners LP Pure Tech Health PLC Transaction History
Diadema Partners LP
- $328 Billion
- Q2 2025
A detailed history of Diadema Partners LP transactions in Pure Tech Health PLC stock. As of the latest transaction made, Diadema Partners LP holds 7,324 shares of PRTC stock, worth $125,240. This represents 0.04% of its overall portfolio holdings.
Number of Shares
7,324Holding current value
$125,240% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding PRTC
# of Institutions
8Shares Held
111KCall Options Held
0Put Options Held
0-
Pentwater Capital Management LP Naples, FL50KShares$855,0000.01% of portfolio
-
Portolan Capital Management, LLC Boston, MA27.8KShares$475,2940.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny23.9KShares$407,9540.0% of portfolio
-
Persistent Asset Partners LTD Hong Kong, K31.69KShares$28,8130.02% of portfolio
-
Ubs Group Ag20Shares$3420.0% of portfolio
About PureTech Health plc
- Ticker PRTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,888,500
- Market Cap $477M
- Description
- PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholi...